Walgreens Closes 1,200 Stores in Three-Year Cost Reduction Plan
The closure program, accelerated after a private-equity acquisition, tests whether large-scale retail pharmacy consolidation affects federal drug access programs and state Medicaid networks.
Walgreens has shuttered locations across at least a dozen states, including New York and New Jersey, as part of a multiyear closure program first disclosed in October 2024, according to reporting by the New York Post citing company announcements. The Chicago-based chain announced plans to close approximately 1,200 underperforming stores over three years, with roughly 500 locations targeted for closure in fiscal year 2025 alone, with a stated goal of reducing operating costs by $1 billion.
The closure timeline accelerated following Walgreens' transition to private ownership. The company was acquired by private-equity firm Sycamore Partners, which completed the transaction taking Walgreens off public markets. The precise closing date of that acquisition and its final transaction value are matters of public record filed with the Securities and Exchange Commission; the SEC filing number was not confirmed independently by this publication at time of publication.
The federal policy dimension of the closures centers on Walgreens' role as a Medicare Part D and Medicaid preferred pharmacy network participant. CMS data published on USASpending.gov lists Walgreens as a contracted pharmacy provider under multiple federal programs. The number of closed locations that participated in those federal contracts, and whether beneficiaries in affected ZIP codes retain access to an in-network pharmacy within a federally defined reasonable distance standard, is not confirmed in currently available public records.
At the congressional level, the Senate Finance Committee and House Energy and Commerce Committee each hold jurisdiction over Medicare and Medicaid pharmacy access standards. Neither committee had scheduled a hearing on retail pharmacy network adequacy as of the publication date of this article, according to publicly posted committee calendars on congress.gov. No legislation specifically addressing large-scale pharmacy chain closures had been introduced in the 119th Congress as of August 4, 2026, per the congressional record.
What remains unknown is the specific list of closed ZIP codes, how many closures affect communities designated as pharmacy deserts under CMS criteria, and what contractual obligations — if any — Walgreens or Sycamore Partners bear to federal program administrators upon closure of a participating location. Those details would be found in Walgreens' CMS pharmacy participation agreements, its SEC transition filings, and any state Medicaid agency network adequacy reports filed with CMS under 42 CFR Part 438.